2023-08-22 15:20:41 ET
More on Regeneron Pharmaceuticals
- Regeneron Gets Boost With FDA Approval Of High-Dose Eylea (Rating Upgrade)
- Regeneron Pharmaceuticals Inc. ( REGN ) Q2 2023 Earnings Call Transcript
- Regeneron: CRL For High Dose Eylea Gives Vabysmo A Wider Opening
- Regeneron Pharmaceuticals: Overdependence On Eylea Brought To The Forefront
- Regeneron, J&J receive millions to develop new COVID therapies
- With two approvals in one day, Regeneron could be headed higher
- Regeneron high-dose Eylea gains FDA approval
- Regeneron wins approval for rare immune disease therapy pozelimab
- Seeking Alpha’s Quant Rating on Regeneron Pharmaceuticals
- Earnings data for Regeneron Pharmaceuticals
- Dividend for Regeneron Pharmaceuticals
For further details see:
Canaccord ups Regeneron to buy, sees high-dose Eylea re-igniting sales